High cost of new cancer drugs in US not related to their effectiveness, study shows
The high costs of recently licensed cancer medicines in the United States—as compared with those in Australia, France and the UK—do not translate into improved survival, quality of life, or safety for patients, according ...
May 26, 2020
0
2